The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”

DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP coding logic example. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP pre-payment and provider behavior mechanism. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Raw data. by Changzhi Liu (518454)

“…Similar findings were observed for the RC-to-cholesterol ratio (aHR: 0.40, 95% CI: 0.21–0.79). …”

Baseline characteristics of the subjects. by Changzhi Liu (518454)

“…Similar findings were observed for the RC-to-cholesterol ratio (aHR: 0.40, 95% CI: 0.21–0.79). …”

S1 Raw images - by Yoon Seok Nam (20678482)

“…The TSA-treated group exhibited a reduction in the levels of oxidative stress markers 4-Hydroxynonenal and 3-Nitrotyrosine, along with a decrease in inflammatory cytokines, in both the mouse cochlea and in vitro HEI-OC1 (House Ear Institute-Organ of Corti 1) cell and HEK (Human Embryonic Kidney)293T cells. …”

I Optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

ANOVA for I optimal design of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

The kinetic release data of the optimized formula compared to drug suspension. by Randa Mohammed Zaki (21637175)

Results for fibrin dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

Mapping of transposon insertions in the selected mutants of <i>M</i>. <i>bovis</i> PG45. by Aga E. Gelgie (17661720)

Polygenic adaptation analysis results for the pairwise and multi-population tests for polygenic adaptation (see Methods). by Olivia A. Gray (20700832)

“…The SNP no. column shows how many SNPS are included in the test at this significance threshold. Significant <i>p</i>-values are highlighted in green (figures for all significant Multi-population tests in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011570#pgen.1011570.s006" target="_blank">S6 Fig</a>). …”